BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 15752754)

  • 1. Identification and characterization of murine DNAM-1 (CD226) and its poliovirus receptor family ligands.
    Tahara-Hanaoka S; Miyamoto A; Hara A; Honda S; Shibuya K; Shibuya A
    Biochem Biophys Res Commun; 2005 Apr; 329(3):996-1000. PubMed ID: 15752754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule.
    Bottino C; Castriconi R; Pende D; Rivera P; Nanni M; Carnemolla B; Cantoni C; Grassi J; Marcenaro S; Reymond N; Vitale M; Moretta L; Lopez M; Moretta A
    J Exp Med; 2003 Aug; 198(4):557-67. PubMed ID: 12913096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNAM-1 and PVR regulate monocyte migration through endothelial junctions.
    Reymond N; Imbert AM; Devilard E; Fabre S; Chabannon C; Xerri L; Farnarier C; Cantoni C; Bottino C; Moretta A; Dubreuil P; Lopez M
    J Exp Med; 2004 May; 199(10):1331-41. PubMed ID: 15136589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PVR (CD155) and Nectin-2 (CD112) as ligands of the human DNAM-1 (CD226) activating receptor: involvement in tumor cell lysis.
    Pende D; Bottino C; Castriconi R; Cantoni C; Marcenaro S; Rivera P; Spaggiari GM; Dondero A; Carnemolla B; Reymond N; Mingari MC; Lopez M; Moretta L; Moretta A
    Mol Immunol; 2005 Feb; 42(4):463-9. PubMed ID: 15607800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneous expression of the adhesion receptor CD226 on murine NK and T cells and its function in NK-mediated killing of immature dendritic cells.
    Seth S; Georgoudaki AM; Chambers BJ; Qiu Q; Kremmer E; Maier MK; Czeloth N; Ravens I; Foerster R; Bernhardt G
    J Leukoc Biol; 2009 Jul; 86(1):91-101. PubMed ID: 19380711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The requirement for DNAM-1, NKG2D, and NKp46 in the natural killer cell-mediated killing of myeloma cells.
    El-Sherbiny YM; Meade JL; Holmes TD; McGonagle D; Mackie SL; Morgan AW; Cook G; Feyler S; Richards SJ; Davies FE; Morgan GJ; Cook GP
    Cancer Res; 2007 Sep; 67(18):8444-9. PubMed ID: 17875681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional characterization of DNAM-1 (CD226) interaction with its ligands PVR (CD155) and nectin-2 (PRR-2/CD112).
    Tahara-Hanaoka S; Shibuya K; Onoda Y; Zhang H; Yamazaki S; Miyamoto A; Honda S; Lanier LL; Shibuya A
    Int Immunol; 2004 Apr; 16(4):533-8. PubMed ID: 15039383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNAM-1/CD155 interactions promote cytokine and NK cell-mediated suppression of poorly immunogenic melanoma metastases.
    Chan CJ; Andrews DM; McLaughlin NM; Yagita H; Gilfillan S; Colonna M; Smyth MJ
    J Immunol; 2010 Jan; 184(2):902-11. PubMed ID: 20008292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural killer cell-mediated killing of freshly isolated neuroblastoma cells: critical role of DNAX accessory molecule-1-poliovirus receptor interaction.
    Castriconi R; Dondero A; Corrias MV; Lanino E; Pende D; Moretta L; Bottino C; Moretta A
    Cancer Res; 2004 Dec; 64(24):9180-4. PubMed ID: 15604290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor rejection by the poliovirus receptor family ligands of the DNAM-1 (CD226) receptor.
    Tahara-Hanaoka S; Shibuya K; Kai H; Miyamoto A; Morikawa Y; Ohkochi N; Honda S; Shibuya A
    Blood; 2006 Feb; 107(4):1491-6. PubMed ID: 16249389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNAX accessory molecule-1 (CD226) promotes human hepatocellular carcinoma cell lysis by Vgamma9Vdelta2 T cells.
    Toutirais O; Cabillic F; Le Friec G; Salot S; Loyer P; Le Gallo M; Desille M; de La Pintière CT; Daniel P; Bouet F; Catros V
    Eur J Immunol; 2009 May; 39(5):1361-8. PubMed ID: 19404979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of cell adhesion molecule nectin-2/CD112 and its binding to immune receptor DNAM-1/CD226.
    Liu J; Qian X; Chen Z; Xu X; Gao F; Zhang S; Zhang R; Qi J; Gao GF; Yan J
    J Immunol; 2012 Jun; 188(11):5511-20. PubMed ID: 22547693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNAM-1: an amplifier of immune responses as a therapeutic target in various disorders.
    Elishmereni M; Bachelet I; Levi-Schaffer F
    Curr Opin Investig Drugs; 2008 May; 9(5):491-6. PubMed ID: 18465659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and Characterization of Novel Monoclonal Antibodies Against Human DNAM-1.
    Okumura G; Abe F; Hirochika R; Shibuya A; Shibuya K
    Monoclon Antib Immunodiagn Immunother; 2017 Jun; 36(3):135-139. PubMed ID: 28498033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment and characterization of a novel anti-DNAM-1 monoclonal antibody.
    Yamashita Y; Abe F; Hirochika R; Tahara-Hanaoka S; Shibuya A; Shibuya K
    Monoclon Antib Immunodiagn Immunother; 2013 Feb; 32(1):60-4. PubMed ID: 23600509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD226 (DNAM-1) is involved in lymphocyte function-associated antigen 1 costimulatory signal for naive T cell differentiation and proliferation.
    Shibuya K; Shirakawa J; Kameyama T; Honda S; Tahara-Hanaoka S; Miyamoto A; Onodera M; Sumida T; Nakauchi H; Miyoshi H; Shibuya A
    J Exp Med; 2003 Dec; 198(12):1829-39. PubMed ID: 14676297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The adhesion receptor CD155 determines the magnitude of humoral immune responses against orally ingested antigens.
    Maier MK; Seth S; Czeloth N; Qiu Q; Ravens I; Kremmer E; Ebel M; Müller W; Pabst O; Förster R; Bernhardt G
    Eur J Immunol; 2007 Aug; 37(8):2214-25. PubMed ID: 17621371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding mode of the side-by-side two-IgV molecule CD226/DNAM-1 to its ligand CD155/Necl-5.
    Wang H; Qi J; Zhang S; Li Y; Tan S; Gao GF
    Proc Natl Acad Sci U S A; 2019 Jan; 116(3):988-996. PubMed ID: 30591568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LFA-1-dependent lipid raft recruitment of DNAM-1 (CD226) in CD4+ T cell.
    Shirakawa J; Wang Y; Tahara-Hanaoka S; Honda S; Shibuya K; Shibuya A
    Int Immunol; 2006 Jun; 18(6):951-7. PubMed ID: 16636013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the DNAM-1 ligands, Nectin-2 (CD112) and poliovirus receptor (CD155), on dendritic cells: relevance for natural killer-dendritic cell interaction.
    Pende D; Castriconi R; Romagnani P; Spaggiari GM; Marcenaro S; Dondero A; Lazzeri E; Lasagni L; Martini S; Rivera P; Capobianco A; Moretta L; Moretta A; Bottino C
    Blood; 2006 Mar; 107(5):2030-6. PubMed ID: 16304049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.